IBDEI39Z ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52274,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,52274,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,52275,0)
 ;;=E11.41^^193^2527^6
 ;;^UTILITY(U,$J,358.3,52275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52275,1,3,0)
 ;;=3^DM Type 2 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,52275,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,52275,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,52276,0)
 ;;=E11.42^^193^2527^13
 ;;^UTILITY(U,$J,358.3,52276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52276,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,52276,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,52276,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,52277,0)
 ;;=E11.43^^193^2527^2
 ;;^UTILITY(U,$J,358.3,52277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52277,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,52277,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,52277,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,52278,0)
 ;;=E11.44^^193^2527^1
 ;;^UTILITY(U,$J,358.3,52278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52278,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,52278,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,52278,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,52279,0)
 ;;=E11.49^^193^2527^8
 ;;^UTILITY(U,$J,358.3,52279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52279,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,52279,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,52279,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,52280,0)
 ;;=E11.59^^193^2527^25
 ;;^UTILITY(U,$J,358.3,52280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52280,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,52280,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,52280,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,52281,0)
 ;;=E11.610^^193^2527^9
 ;;^UTILITY(U,$J,358.3,52281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52281,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,52281,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,52281,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,52282,0)
 ;;=E11.618^^193^2527^26
 ;;^UTILITY(U,$J,358.3,52282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52282,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,52282,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,52282,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,52283,0)
 ;;=E11.621^^193^2527^16
 ;;^UTILITY(U,$J,358.3,52283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52283,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,52283,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,52283,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,52284,0)
 ;;=E11.622^^193^2527^31
 ;;^UTILITY(U,$J,358.3,52284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52284,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,52284,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,52284,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,52285,0)
 ;;=E11.628^^193^2527^30
 ;;^UTILITY(U,$J,358.3,52285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52285,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,52285,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,52285,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,52286,0)
 ;;=E11.630^^193^2527^33
 ;;^UTILITY(U,$J,358.3,52286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52286,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,52286,1,4,0)
 ;;=4^E11.630
